These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 25331226)
21. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. Gilmore HJ; Liu A; Koester KA; Amico KR; McMahan V; Goicochea P; Vargas L; Lubensky D; Buchbinder S; Grant R AIDS Patient Care STDS; 2013 Oct; 27(10):560-6. PubMed ID: 24093809 [TBL] [Abstract][Full Text] [Related]
22. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
23. HIV pre-exposure prophylaxis for men who have sex with men in west Africa: a multicountry demonstration study. Laurent C; Dembélé Keita B; Yaya I; Le Guicher G; Sagaon-Teyssier L; Agboyibor MK; Coulibaly A; Traoré I; Malan JB; De Baetselier I; Eubanks A; Riegel L; Rojas Castro D; Fayé-Ketté H; Koné A; Diandé S; Dagnra CA; Serrano L; Diallo F; Mensah E; Dah TTE; Anoma C; Vuylsteke B; Spire B; Lancet HIV; 2021 Jul; 8(7):e420-e428. PubMed ID: 34048794 [TBL] [Abstract][Full Text] [Related]
24. Small-area spatial-temporal changes in pre-exposure prophylaxis (PrEP) use in the general population and among men who have sex with men in the United States between 2012 and 2018. Mouhanna F; Castel AD; Sullivan PS; Kuo I; Hoffman HJ; Siegler AJ; Jones JS; Mera Giler R; McGuinness P; Kramer MR Ann Epidemiol; 2020 Sep; 49():1-7. PubMed ID: 32951802 [TBL] [Abstract][Full Text] [Related]
25. Early experience of implementing a national HIV pre-exposure prophylaxis service in Wales, United Kingdom 2017. Fina L; Phillips AL; Jones AT; Couzens ZM; Drayton R; Thomas DR; Shankar AG Sex Health; 2019 Feb; 16(1):56-62. PubMed ID: 30501846 [TBL] [Abstract][Full Text] [Related]
26. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation. Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706 [TBL] [Abstract][Full Text] [Related]
27. From modeling to morals: imagining the future of HIV PREP in Lesotho. Kenworthy NJ; Bulled N Dev World Bioeth; 2013 Aug; 13(2):70-8. PubMed ID: 23800326 [TBL] [Abstract][Full Text] [Related]
28. Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study. Marins LMS; Torres TS; Leite IDC; Moreira RI; Luz PM; Hoagland B; Kallas EG; Madruga JV; Liu AY; Anderson PL; Grinsztejn B; Veloso VG PLoS One; 2019; 14(8):e0221281. PubMed ID: 31430318 [TBL] [Abstract][Full Text] [Related]
29. Social Support Networks Among Young Men and Transgender Women of Color Receiving HIV Pre-Exposure Prophylaxis. Wood S; Dowshen N; Bauermeister JA; Lalley-Chareczko L; Franklin J; Petsis D; Swyryn M; Barnett K; Weissman GE; Koenig HC; Gross R J Adolesc Health; 2020 Mar; 66(3):268-274. PubMed ID: 31672523 [TBL] [Abstract][Full Text] [Related]
30. An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM. Hosek SG; Rudy B; Landovitz R; Kapogiannis B; Siberry G; Rutledge B; Liu N; Brothers J; Mulligan K; Zimet G; Lally M; Mayer KH; Anderson P; Kiser J; Rooney JF; Wilson CM; J Acquir Immune Defic Syndr; 2017 Jan; 74(1):21-29. PubMed ID: 27632233 [TBL] [Abstract][Full Text] [Related]
31. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. Mutua G; Sanders E; Mugo P; Anzala O; Haberer JE; Bangsberg D; Barin B; Rooney JF; Mark D; Chetty P; Fast P; Priddy FH PLoS One; 2012; 7(4):e33103. PubMed ID: 22511916 [TBL] [Abstract][Full Text] [Related]
32. Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand. Sineath RC; Finneran C; Sullivan P; Sanchez T; Smith DK; Griensven Fv; Wimonsate W; Stephenson R J Int Assoc Provid AIDS Care; 2013; 12(4):227-31. PubMed ID: 23708677 [TBL] [Abstract][Full Text] [Related]
33. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM). Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061 [TBL] [Abstract][Full Text] [Related]
34. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP). Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439 [TBL] [Abstract][Full Text] [Related]
35. FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis. Corneli AL; Deese J; Wang M; Taylor D; Ahmed K; Agot K; Lombaard J; Manongi R; Kapiga S; Kashuba A; Van Damme L; J Acquir Immune Defic Syndr; 2014 Jul; 66(3):324-31. PubMed ID: 25157647 [TBL] [Abstract][Full Text] [Related]
36. Feasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk. Egan JE; Ho K; Stall R; Drucker MT; Tappin R; Hendrix CW; Marzinke MA; Safren SA; Mimiaga MJ; Psaros C; Elsesser S; Mayer KH J Acquir Immune Defic Syndr; 2020 Aug; 84(5):508-513. PubMed ID: 32692109 [TBL] [Abstract][Full Text] [Related]
37. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial. Mayer KH; Molina JM; Thompson MA; Anderson PL; Mounzer KC; De Wet JJ; DeJesus E; Jessen H; Grant RM; Ruane PJ; Wong P; Ebrahimi R; Zhong L; Mathias A; Callebaut C; Collins SE; Das M; McCallister S; Brainard DM; Brinson C; Clarke A; Coll P; Post FA; Hare CB Lancet; 2020 Jul; 396(10246):239-254. PubMed ID: 32711800 [TBL] [Abstract][Full Text] [Related]
38. Adherence to PrEP Among Young Men Who Have Sex With Men Participating in a Sexual Health Services Demonstration Project in Alameda County, California. Myers JJ; Kang Dufour MS; Koester KA; Udoh I; Frazier R; Packard R; Kennedy K; Erguera X; Horowitz J; Grant R; Burack JH J Acquir Immune Defic Syndr; 2019 Aug; 81(4):406-413. PubMed ID: 30973542 [TBL] [Abstract][Full Text] [Related]
39. Plasma Tenofovir Levels to Support Adherence to TDF/FTC Preexposure Prophylaxis for HIV Prevention in MSM in Los Angeles, California. Landovitz RJ; Beymer M; Kofron R; Amico KR; Psaros C; Bushman L; Anderson PL; Flynn R; Lee DP; Bolan RK; Jordan WC; Tseng CH; Dierst-Davies R; Rooney J; Wohl AR J Acquir Immune Defic Syndr; 2017 Dec; 76(5):501-511. PubMed ID: 28902074 [TBL] [Abstract][Full Text] [Related]
40. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial. Wang H; Wang Z; Huang X; Chen Y; Wang H; Cui S; Zhang J; Chu Z; Hu Q; Ding H; Qian H; Zou H; Tang W; Gao Y; Jin X; Liu Z; Zhang L; Zhao J; He X; Jiang Y; Geng W; Xu J; Shang H; JAMA Netw Open; 2022 Feb; 5(2):e2148782. PubMed ID: 35171258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]